Positioning no disclosures inside 60 days, left as found
Options put/call open interest 1.51, read 2026-10-27
Ethical does not pass the values gate
Price144.67 USD
Fair value205.00
Our investment reviews on this name
2026-10-23Read Accumulation144.35+0.2% to today ✓Markup gives way to Accumulation after an 8% rise in 3 weeks
2026-10-02Read Markup134.16+7.8% to today ✓Distribution gives way to Markup after a 33% slide in 6 weeks
2026-08-18Read Distribution200.32-27.8% to today ✓Markup gives way to Distribution after a 7% slide in 7 weeks
2026-07-02Read Markup214.83-32.7% to today First review on file: Markup
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
DICK'S Sporting Goods, Inc. holds its Accumulation at $144.67. Consolidating, no directional conviction, held for 20 days.
As held on the ledger · 2026-10-23
Phase
Accumulation
Quantitative state
Consolidating, no directional conviction, held for 20 days
Price at the screen
$144.67
Valuation
15.67 trailing · 10.98 forward price to earnings
Values screen
FAIL
Beta
1.10
The Workings
Five Screens, Shown in Full
Does not pass. Debt ratio
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
37.99%
Below 33%
Interest-bearing debt is 38.0% of its assets, above the one-third ceiling the screen allows.
Fail
Interest-bearing cash
6.64%
Below 33%
Cash held in interest-bearing accounts and securities is 6.6% of assets, under the one-third limit.
Pass
Receivables
0.00%
Below 49%
Money owed to the company is 0.0% of assets, under the 49% limit.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Falls Short, in Plain English
DICK'S Sporting Goods,'s business is in a permissible area, but its interest-bearing debt is about 38% of the company, just over the ~33% line, so it does not pass on the financial screens.
Read as at 2026-10-28. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when DKS's ethical verdict changes
Today DKS does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
Fair value range in USD, drawn from the 2026-10-23 screen. The gold marker is the market price at the same screen. A 41.7% margin of safety to the base estimate.
Third-party analyst targets: 23 covering, consensus Buy. The average target sits +18% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-10-23 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Debt screen blocks sporting goods retailer
Think of a shopper piling gear into a trolley at peak season only to watch the store's own bills mount faster than sales. Dick's shows 63 percent revenue growth, 21 percent ROE and a moderate moat, yet we pass because the ethical screen flags its debt ratio as unacceptable.
The forward multiple of 13.3 times looks tempting next to a $300 fair value, and twenty-two analysts lean buy. None of that matters once the balance sheet raises red flags that our screen is built to catch.
Consumer cyclical exposure adds the usual warning that peak earnings can shrink quickly and leave a low multiple looking expensive after the fact. Analysis, not advice.
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
DKS trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The framework has shifted from markup to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 4.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are up 21%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (22 analysts) rates it buy, with a mean price target of $240.
2026-10-16Markup$137.55+2.5%Entry 14
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 2.5% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are up 21%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (22 analysts) rates it buy, with a mean price target of $240.
2026-10-02Markup · changed$134.16-26.8%Entry 13
The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 26.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are up 21%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (22 analysts) rates it buy, with a mean price target of $240.
2026-08-25Distribution$183.23+0.0%Entry 12
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are up 21%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (22 analysts) rates it buy, with a mean price target of $240. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-24Distribution$183.23+0.0%Entry 11
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are up 21%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (22 analysts) rates it buy, with a mean price target of $240. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-23Distribution$183.23+0.0%Entry 10
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are up 21%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (22 analysts) rates it buy, with a mean price target of $240. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-22Distribution$183.23-8.5%Entry 9
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 8.5% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are up 21%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (22 analysts) rates it buy, with a mean price target of $240. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-21Distribution$200.32+0.0%Entry 8
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are up 21%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (22 analysts) rates it buy, with a mean price target of $240. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-20Distribution$200.32+0.0%Entry 7
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are up 21%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (22 analysts) rates it buy, with a mean price target of $240. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-19Distribution$200.32+0.0%Entry 6
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are up 21%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (22 analysts) rates it buy, with a mean price target of $240. It reported earnings in this window, a natural checkpoint for the thesis.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
